Blackstone Inc’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,577
Closed -$1.47M 580
2026
Q1
$1.47M Buy
+10,577
New +$1.48M 0.01% 223
2025
Q4
Sell
-13,532
Closed -$1.5M 272
2025
Q3
$1.5M Buy
+13,532
New +$1.54M 0.01% 155

Other funds holding GILD

Blackstone Inc's GILD Position: Q2 2026 in Review

Blackstone Inc sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 10,577 shares — an estimated $1.47M sold.

Blackstone Inc first reported a position in GILD in Q3 2025 and held it in 2 quarters. The position peaked at $1.5M in Q3 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Blackstone Inc reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Blackstone Inc sold 10,577 Gilead Sciences shares in Q2 2026, an estimated $1.47M.
  • Blackstone Inc first reported a position in Gilead Sciences in Q3 2025 and held it in 2 quarters.
  • Blackstone Inc's Gilead Sciences position peaked at $1.5M in Q3 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Blackstone Inc's 13F filing for Q2 2026, filed 14 Aug 2026.